Nonetheless, OXM or itspharmacological analogues may still play a role in treating obesity, insulinresistance, and glucose intolerance (5, 6), offeringpotential benefits for a significant subset of women with PCOS who also suffer fromthese comorbidities. This evidence concerns the gene GCG and polycystic ovary syndrome.